Keren Regev

2.0k total citations
65 papers, 1.4k citations indexed

About

Keren Regev is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Keren Regev has authored 65 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 18 papers in Molecular Biology and 13 papers in Neurology. Recurrent topics in Keren Regev's work include Multiple Sclerosis Research Studies (22 papers), Retinal and Optic Conditions (7 papers) and MicroRNA in disease regulation (6 papers). Keren Regev is often cited by papers focused on Multiple Sclerosis Research Studies (22 papers), Retinal and Optic Conditions (7 papers) and MicroRNA in disease regulation (6 papers). Keren Regev collaborates with scholars based in Israel, United States and Germany. Keren Regev's co-authors include Arnon Karni, Eitan Auriel, Pia Kivisäkk, Howard L. Weiner, Roopali Gandhi, Brian C. Healy, Amos D. Korczyn, Bonnie I. Glanz, Maria Antonietta Mazzola and Sandra Cook and has published in prestigious journals such as The Journal of Physical Chemistry B, Neurology and Annals of Neurology.

In The Last Decade

Keren Regev

61 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keren Regev Israel 22 619 326 234 219 130 65 1.4k
Mehrdokht Mazdeh Iran 20 458 0.7× 259 0.8× 104 0.4× 348 1.6× 107 0.8× 115 1.3k
Jun Ma China 20 404 0.7× 127 0.4× 203 0.9× 99 0.5× 212 1.6× 114 1.7k
Carlo Avolio Italy 22 398 0.6× 680 2.1× 286 1.2× 279 1.3× 191 1.5× 75 1.8k
Antonio Bruno Italy 24 684 1.1× 287 0.9× 103 0.4× 86 0.4× 177 1.4× 83 1.8k
Michael Pike United Kingdom 24 459 0.7× 220 0.7× 616 2.6× 91 0.4× 95 0.7× 61 1.9k
Marie Hanscom United States 20 599 1.0× 94 0.3× 292 1.2× 61 0.3× 218 1.7× 26 1.3k
Xue Yao China 23 825 1.3× 522 1.6× 66 0.3× 375 1.7× 140 1.1× 65 1.9k
Zhigang He China 24 573 0.9× 107 0.3× 66 0.3× 280 1.3× 58 0.4× 92 1.8k

Countries citing papers authored by Keren Regev

Since Specialization
Citations

This map shows the geographic impact of Keren Regev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keren Regev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keren Regev more than expected).

Fields of papers citing papers by Keren Regev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keren Regev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keren Regev. The network helps show where Keren Regev may publish in the future.

Co-authorship network of co-authors of Keren Regev

This figure shows the co-authorship network connecting the top 25 collaborators of Keren Regev. A scholar is included among the top collaborators of Keren Regev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keren Regev. Keren Regev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zanotto, Tobia, Anat Mirelman, Keren Regev, et al.. (2024). Effects of a 6-Week Treadmill Training With and Without Virtual Reality on Frailty in People With Multiple Sclerosis. Archives of Physical Medicine and Rehabilitation. 106(2). 187–194. 3 indexed citations
3.
Shiner, Tamara, Gitit Kavé, Anat Mirelman, et al.. (2024). Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies. Movement Disorders. 39(12). 2280–2285. 1 indexed citations
4.
Gazit, Eran, et al.. (2024). Gait and heart rate: do they measure trait or state physical fatigue in people with multiple sclerosis?. Journal of Neurology. 271(7). 4462–4472.
5.
Bregman, Noa, Gitit Kavé, Arnon Karni, et al.. (2024). Long-term cognitive outcomes in Susac syndrome: A case series. Journal of Neuroimmunology. 393. 578396–578396. 1 indexed citations
6.
Petrou, Panayiota, Anat Achiron, David Magalashvili, et al.. (2023). Practical recommendations on treatment of multiple sclerosis with Cladribine: an Israeli Experts Group Viewpoint. Journal of Neurology. 270(11). 5188–5195. 3 indexed citations
7.
Zanotto, Tobia, Anat Mirelman, Lingjun Chen, et al.. (2023). Association Between Frailty and Free-Living Walking Performance in People With Multiple Sclerosis. Physical Therapy. 103(5). 8 indexed citations
8.
Karni, Arnon, et al.. (2023). Olfactory function in Susac syndrome. Clinical Neurology and Neurosurgery. 233. 107909–107909. 1 indexed citations
9.
Fuchs, Lior, Karin Mausner-Fainberg, Susanna Asseyer, et al.. (2022). CTGF/CCN2 has a possible detrimental role in the inflammation and the remyelination failure in the early stages of multiple sclerosis. Journal of Neuroimmunology. 371. 577936–577936. 4 indexed citations
10.
Kolb, Hadar, et al.. (2022). BNT162b2 mRNA COVID-19 Vaccine Three-Dose Safety and Risk of COVID-19 in Patients With Myasthenia Gravis. Neurology. 99(23_Supplement_2). 1 indexed citations
11.
Zur, Dinah, Michaella Goldstein, Yahav Oron, et al.. (2021). Susac’s syndrome – A new ocular finding and disease outcome. Eye. 36(4). 781–788. 4 indexed citations
12.
Thaler, Avner, Nir Giladi, Tanya Gurevich, et al.. (2021). Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers. Journal of Parkinson s Disease. 11(3). 1285–1296. 20 indexed citations
13.
Golan, Maya, et al.. (2021). Increased Expression of Ephrins on Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis Affects Oligodendrocyte Differentiation. International Journal of Molecular Sciences. 22(4). 2182–2182. 3 indexed citations
14.
Hsieh, Katherine L., Anat Mirelman, Shirley Shema-Shiratzky, et al.. (2020). A multi-modal virtual reality treadmill intervention for enhancing mobility and cognitive function in people with multiple sclerosis: Protocol for a randomized controlled trial. Contemporary Clinical Trials. 97. 106122–106122. 15 indexed citations
15.
Regev, Keren, et al.. (2019). Isolated recurrent myelitis in a persistent MOG positive patient. Multiple Sclerosis and Related Disorders. 30. 163–164. 4 indexed citations
16.
Tankou, Stephanie, Keren Regev, Brian C. Healy, et al.. (2018). Investigation of probiotics in multiple sclerosis. Multiple Sclerosis Journal. 24(1). 58–63. 107 indexed citations
17.
Mazzola, Maria Antonietta, Radhika Raheja, Gopal Murugaiyan, et al.. (2015). Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation. Journal of Neuroinflammation. 12(1). 245–245. 34 indexed citations
18.
Auriel, Eitan, Keren Regev, & Amos D. Korczyn. (2013). Nonsteroidal anti-inflammatory drugs exposure and the central nervous system. Handbook of clinical neurology. 119. 577–584. 84 indexed citations
19.
Mausner-Fainberg, Karin, et al.. (2010). Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis. Journal of the Neurological Sciences. 295(1-2). 31–37. 17 indexed citations
20.
Grinstein, M., et al.. (2003). Effect of Molecule−Molecule Interaction on the Electronic Properties of Molecularly Modified Si/SiOxSurfaces. The Journal of Physical Chemistry B. 108(2). 664–672. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehrdokht Mazdeh Breakdown of academic impact, for papers by Jun Ma Breakdown of academic impact, for papers by Carlo Avolio Breakdown of academic impact, for papers by Antonio Bruno Breakdown of academic impact, for papers by Michael Pike Breakdown of academic impact, for papers by Marie Hanscom Breakdown of academic impact, for papers by Xue Yao Breakdown of academic impact, for papers by Zhigang He
Rankless by CCL
2026